The microscopic anatomy of experimental rat CC531 colon tumour metastases: Consequences for immunotherapy?
- 1 January 2000
- journal article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 18 (2) , 189-196
- https://doi.org/10.1023/a:1006774602360
Abstract
The colon adenocarcinoma cell line CC531 was adopted as a model for immunotherapeutical treatment of experimental colorectal metastases in a syngeneic rat model. We studied the presence and localization of T and natural killer cells, vessels and matrix proteins in in vivo growing CC531 tumours by immunohistochemistry. CC531 tumours were induced either in the lungs by injecting CC531 tumour cells into a tail vein or in the liver by injection of CC531 tumour cells under the liver capsule or into a mesenteric vein. All 3 tumour types were composed of islets of tightly apposed tumour cells surrounded by abundantly present tumour-stroma which contained tumour vessels and matrix proteins. Some of these matrix proteins, especially laminin and collagen IV formed a basal membrane-like structure around the tumour nodules. This structure was most pronounced in mesenteric vein-induced liver tumours and less prominent in subcapsular-induced liver tumours and tail vein-induced lung tumours. Tumour-infiltrating lymphocytes of both T and natural killer cell origin were found in the tumours, but predominantly in the tumour stroma, separated from the islets of tumour cells by the basal membrane-like structure. We hypothesize that the matrix proteins of these tumours play an ambivalent role: they may provide a substratum for migration of effector cells into the tumour stroma but may also provide a barrier preventing direct contact between tumour target cells and immune effector cells.Keywords
This publication has 34 references indexed in Scilit:
- Three‐dimensional reconstruction of colon carcinoma metastases in liverJournal of Microscopy, 1997
- Abnormal basement membrane in tumors induced by rat colon cancer cellsGastroenterology, 1994
- T-Cell Retargeting Using Bispecific Monoclonal Antibodies in a Rat Colon Carcinoma Model: IV. Tumor Neutralization in Winn Type AssaysJournal of Immunotherapy, 1993
- Biodistribution of lymphokine‐activated killer (LAK) cells in WAG rats after hepatic‐artery or jugular‐vein infusionInternational Journal of Cancer, 1992
- T-Cell Retargeting Using Bispecific Monoclonal Antibodies in a Rat Colon Carcinoma Model. I. Significant Bispecific Lysis of Syngeneic Colon Carcinoma CC531 Is Critically Dependent on Prolonged Preactivation of Effector T-Lymphocytes by Immobilized Anti-T-Cell Receptor AntibodyJournal of Immunotherapy, 1992
- Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases.The Journal of Experimental Medicine, 1991
- Fibronectin facilitates the migration of human natural killer cellsEuropean Journal of Immunology, 1991
- Structure of Basement Membranes in Malignant Melanoma and Nevocytic Nevi.Journal of Investigative Dermatology, 1989
- Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells.The Journal of Experimental Medicine, 1989
- A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes.The Journal of Experimental Medicine, 1989